Clinicians Connect: Conversations w/ FDA's CMO on reducing cases of congenital syphilis & syphilis

Are you a health care professional and want to learn more about the impact of congenital syphilis and syphilis on your patients? Hear directly from the CDC, FDA, HHS, and NIH about what we can do to address the recent surge in syphilis and its impact on individuals, pregnant people and babies.
Presenters include:
• Hilary Marston, M.D., M.P.H., Chief Medical Officer, Office of the Commissioner, FDA
• Kaye Hayes, M.P.A., Deputy Assistant Secretary for Infectious Disease and Director, Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, HHS
• Susan Bersoff-Matcha, M.D., Deputy Director, Office of Women’s Health, Office of the Commissioner, FDA
• Bradley Stoner, M.D., Ph.D., Director, Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC
• Carolyn D. Deal, Ph.D., Chief, Enteric and Sexually Transmitted Infections Branch, National Institute of Allergy and Infectious Disease, NIH